These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 33478521)
1. Blood-based extracellular matrix biomarkers as predictors of survival in patients with metastatic pancreatic ductal adenocarcinoma receiving pegvorhyaluronidase alfa. Wang S; Bager CL; Karsdal MA; Chondros D; Taverna D; Willumsen N J Transl Med; 2021 Jan; 19(1):39. PubMed ID: 33478521 [TBL] [Abstract][Full Text] [Related]
2. HALO 202: Randomized Phase II Study of PEGPH20 Plus Nab-Paclitaxel/Gemcitabine Versus Nab-Paclitaxel/Gemcitabine in Patients With Untreated, Metastatic Pancreatic Ductal Adenocarcinoma. Hingorani SR; Zheng L; Bullock AJ; Seery TE; Harris WP; Sigal DS; Braiteh F; Ritch PS; Zalupski MM; Bahary N; Oberstein PE; Wang-Gillam A; Wu W; Chondros D; Jiang P; Khelifa S; Pu J; Aldrich C; Hendifar AE J Clin Oncol; 2018 Feb; 36(4):359-366. PubMed ID: 29232172 [TBL] [Abstract][Full Text] [Related]
3. Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcinoma. Van Cutsem E; Tempero MA; Sigal D; Oh DY; Fazio N; Macarulla T; Hitre E; Hammel P; Hendifar AE; Bates SE; Li CP; Hingorani SR; de la Fouchardiere C; Kasi A; Heinemann V; Maraveyas A; Bahary N; Layos L; Sahai V; Zheng L; Lacy J; Park JO; Portales F; Oberstein P; Wu W; Chondros D; Bullock AJ; J Clin Oncol; 2020 Sep; 38(27):3185-3194. PubMed ID: 32706635 [TBL] [Abstract][Full Text] [Related]
4. Collagen fragments quantified in serum as measures of desmoplasia associate with survival outcome in patients with advanced pancreatic cancer. Willumsen N; Ali SM; Leitzel K; Drabick JJ; Yee N; Polimera HV; Nagabhairu V; Krecko L; Ali A; Maddukuri A; Moku P; Ali A; Poulose J; Menon H; Pancholy N; Costa L; Karsdal MA; Lipton A Sci Rep; 2019 Dec; 9(1):19761. PubMed ID: 31875000 [TBL] [Abstract][Full Text] [Related]
5. Blood-based extracellular matrix biomarkers are correlated with clinical outcome after PD-1 inhibition in patients with metastatic melanoma. Hurkmans DP; Jensen C; Koolen SLW; Aerts J; Karsdal MA; Mathijssen RHJ; Willumsen N J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33093157 [TBL] [Abstract][Full Text] [Related]
6. High turnover of extracellular matrix reflected by specific protein fragments measured in serum is associated with poor outcomes in two metastatic breast cancer cohorts. Lipton A; Leitzel K; Ali SM; Polimera HV; Nagabhairu V; Marks E; Richardson AE; Krecko L; Ali A; Koestler W; Esteva FJ; Leeming DJ; Karsdal MA; Willumsen N Int J Cancer; 2018 Dec; 143(11):3027-3034. PubMed ID: 29923614 [TBL] [Abstract][Full Text] [Related]
7. Non-invasive biomarkers derived from the extracellular matrix associate with response to immune checkpoint blockade (anti-CTLA-4) in metastatic melanoma patients. Jensen C; Madsen DH; Hansen M; Schmidt H; Svane IM; Karsdal MA; Willumsen N J Immunother Cancer; 2018 Dec; 6(1):152. PubMed ID: 30567561 [TBL] [Abstract][Full Text] [Related]
8. Impact of Nab-Paclitaxel-based Second-line Chemotherapy in Metastatic Pancreatic Cancer. Dadi N; Stanley M; Shahda S; O'Neil BH; Sehdev A Anticancer Res; 2017 Oct; 37(10):5533-5539. PubMed ID: 28982867 [TBL] [Abstract][Full Text] [Related]
9. Systemic Biomarkers of Collagen and Elastin Turnover Are Associated With Clinically Relevant Outcomes in COPD. Stolz D; Leeming DJ; Kristensen JHE; Karsdal MA; Boersma W; Louis R; Milenkovic B; Kostikas K; Blasi F; Aerts J; Sand JMB; Wouters EFM; Rohde G; Prat C; Torres A; Welte T; Roth M; Papakonstantinou E; Tamm M Chest; 2017 Jan; 151(1):47-59. PubMed ID: 27575358 [TBL] [Abstract][Full Text] [Related]
10. The evolution of clinical outcomes in metastatic pancreatic adenocarcinoma: a 10-year experience at a tertiary referral center. Ellithi M; Abdallah M; Fischer M; Ailts I; Fanta J; Waligoske K; Bell M; Nelson ME; Bleeker J Expert Rev Gastroenterol Hepatol; 2022 May; 16(5):479-486. PubMed ID: 35400291 [TBL] [Abstract][Full Text] [Related]
11. Collagen Biomarkers Quantify Fibroblast Activity In Vitro and Predict Survival in Patients with Pancreatic Ductal Adenocarcinoma. Nissen NI; Johansen AZ; Chen I; Johansen JS; Pedersen RS; Hansen CP; Karsdal MA; Willumsen N Cancers (Basel); 2022 Feb; 14(3):. PubMed ID: 35159087 [TBL] [Abstract][Full Text] [Related]
12. Dynamic Contrast-enhanced MRI Detects Responses to Stroma-directed Therapy in Mouse Models of Pancreatic Ductal Adenocarcinoma. Cao J; Pickup S; Clendenin C; Blouw B; Choi H; Kang D; Rosen M; O'Dwyer PJ; Zhou R Clin Cancer Res; 2019 Apr; 25(7):2314-2322. PubMed ID: 30587546 [TBL] [Abstract][Full Text] [Related]
13. Impact of SPARC expression on outcome in patients with advanced pancreatic cancer not receiving nab-paclitaxel: a pooled analysis from prospective clinical and translational trials. Ormanns S; Haas M; Baechmann S; Altendorf-Hofmann A; Remold A; Quietzsch D; Clemens MR; Bentz M; Geissler M; Lambertz H; Kruger S; Kirchner T; Heinemann V; Boeck S Br J Cancer; 2016 Dec; 115(12):1520-1529. PubMed ID: 27802454 [TBL] [Abstract][Full Text] [Related]
14. Blood-based tumor fibrosis markers as diagnostic and prognostic biomarkers in patients with biliary tract cancer. Christensen TD; Jensen C; Larsen O; Leerhøy B; Hansen CP; Madsen K; Høgdall D; Karsdal MA; Chen IM; Nielsen D; Johansen JS; Willumsen N Int J Cancer; 2023 Mar; 152(5):1036-1049. PubMed ID: 36455598 [TBL] [Abstract][Full Text] [Related]
15. Turnover of type III collagen reflects disease severity and is associated with progression and microinflammation in patients with IgA nephropathy. Genovese F; Boor P; Papasotiriou M; Leeming DJ; Karsdal MA; Floege J Nephrol Dial Transplant; 2016 Mar; 31(3):472-9. PubMed ID: 26311218 [TBL] [Abstract][Full Text] [Related]
16. High turnover of types III and VI collagen in progressive idiopathic pulmonary fibrosis. Hoyer N; Jessen H; Prior TS; Sand JMB; Leeming DJ; Karsdal MA; Åttingsberg EKA; Vangsgaard GKM; Bendstrup E; Shaker SB Respirology; 2021 Jun; 26(6):582-589. PubMed ID: 33834579 [TBL] [Abstract][Full Text] [Related]
17. Plasma miR-181a-5p Downregulation Predicts Response and Improved Survival After FOLFIRINOX in Pancreatic Ductal Adenocarcinoma. Meijer LL; Garajová I; Caparello C; Le Large TYS; Frampton AE; Vasile E; Funel N; Kazemier G; Giovannetti E Ann Surg; 2020 Jun; 271(6):1137-1147. PubMed ID: 30394883 [TBL] [Abstract][Full Text] [Related]
18. Clinical value of serum hyaluronan and propeptide of type III collagen in patients with pancreatic cancer. Chen IM; Willumsen N; Dehlendorff C; Johansen AZ; Jensen BV; Hansen CP; Hasselby JP; Bojesen SE; Pfeiffer P; Nielsen SE; Holländer NH; Yilmaz MK; Karsdal M; Johansen JS Int J Cancer; 2020 May; 146(10):2913-2922. PubMed ID: 31642523 [TBL] [Abstract][Full Text] [Related]
19. A systemic inflammation response index (SIRI) correlates with survival and predicts oncological outcome for mFOLFIRINOX therapy in metastatic pancreatic cancer. Pacheco-Barcia V; Mondéjar Solís R; France T; Asselah J; Donnay O; Zogopoulos G; Bouganim N; Guo K; Rogado J; Martin E; Alcindor T; Colomer R Pancreatology; 2020 Mar; 20(2):254-264. PubMed ID: 31866391 [TBL] [Abstract][Full Text] [Related]
20. Dysregulation of circulating collagen turnover markers in very early systemic sclerosis. Dobrota R; Jordan S; Juhl P; Del Papa N; Maurer B; Becker M; Mihai C; Bay-Jensen AC; Karsdal MA; Siebuhr AS; Distler O RMD Open; 2024 May; 10(2):. PubMed ID: 38806188 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]